Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

33 results about "Lincomycin" patented technology

This medication is used to treat a wide variety of bacterial infections.

Method for detecting lincomycin in milk based on background fluorescence quenching-immunochromatography

The invention relates to the technical field of milk detection, and discloses a method for detecting lincomycin in milk based on background fluorescence quenching-immunochromatography. The method for detecting lincomycin in milk based on background fluorescence quenching-immunochromatography comprises the following steps: 1, inputting a lincomycin standard curve equation and a name to a two-dimensional code encoder in order to make a lincomycin two-dimensional code, and pasting the lincomycin two-dimensional code in the two-dimensional code pasting position of a lincomycin test strip in order to obtain a lincomycin detection card; and 2, taking 200 [mu]L of a sample to be detected to a small test cup fixedly containing a colloidal-gold antibody. The detection limit of lincomycin in milk n is 0.088 [mu]g/kg, the optimal sample addition volume is 100 [mu]L, and the optimal chromatographic time is 10 min. Compared with existing methods, the method disclosed in the invention has the advantages of high sensitivity, short reaction time and easiness in operation, can realize onsite rapid quantitative detection of lincomycin in the milk, and lays a foundation for the wide application to the field of food safety.
Owner:THE CENT FOR DISEASE CONTROL & PREVENTION OF XINJIANG UYGUR AUTONOMOUS REGION

Preparation method and application of MOFs composite TiO2 photoactive material electrode

PendingCN113607767AFeasible Implementation StrategiesPrecise control of hollowMaterial analysis using wave/particle radiationColor/spectral properties measurementsBio moleculesComposite electrode
The invention belongs to the technical field of photoelectrochemical analysis, and particularly relates to a preparation method and application of an MOFs composite TiO2 photoactive material electrode. The preparation method comprises the following steps of S01, preparing HKUST-1, S02, dropwise adding the TiO2 dispersion liquid on an ITO electrode, S03, preparing an HKUST-1/TiO2/ITO modified electrode, and S04, preparing a CS/HKUST-1/TiO2/ITO composite electrode. The step S04 is replaced by the step S04', and the step S04' comprises the substeps that the HKUST-1/TiO2/ITO modified electrode obtained in the step S03 is heated to 300-380 DEG C at the speed of 8-12 DEG C/min, roasted for 0.8-1.5 h and cooled, and then the HKUST-CuO/TiO2/ITO composite electrode is obtained. The hollow and thin-layer defect structure of HKUST-CuO is beneficial to enhancing the multiple diffuse reflection effect on visible light, a sensor platform can be further applied to high-sensitivity detection of other biomolecules such as alpha fetoprotein (AFP), lincomycin (Lin) and heavy metal ions Hg<2+>, and meanwhile, the composite material also has an obvious effect on catalytic degradation of dye molecules.
Owner:广东五研检测技术有限公司

Liquid chromatography-mass spectrometry method for simultaneously determining lincomycin and gentamicin in animal blood plasma

The invention discloses a liquid chromatography-mass spectrometry method for simultaneously determining lincomycin and gentamicin in animal blood plasma. The liquid chromatography-mass spectrometry method for simultaneously determining the lincomycin and the gentamicin in the animal blood plasma, disclosed by the invention, comprises the following steps: (1) simultaneously extracting the lincomycin and the gentamicin in blood plasma to be detected by utilizing an extracting solvent, so as to obtain an extracting solution; (2) carrying out qualitative and quantitative determination on the extracting solution by adopting a high performance liquid chromatography tandem mass spectrometry. According to the liquid chromatography-mass spectrometry method disclosed by the invention, the lincomycin and the gentamicin in the blood serum can be simultaneously extracted by utilizing the same extracting reagent, so that a complicated process of extracting step by step is avoided; an ion pair reagent is not used in a sample pre-treatment process and normal utilization of an instrument is not influenced. A method for pre-treating a blood serum sample and the liquid chromatography-mass spectrometry method have the advantages of simple steps, high sensitivity and accurate and reliable result and can be used for simply and efficiently determining the lincomycin and the gentamicin in the animal blood plasma.
Owner:哈尔滨绿达生动物药业有限公司

Compound astragalus polysaccharide injection used for pigs and preparation method thereof

The invention discloses compound astragalus polysaccharide injection used for pigs and a preparation method thereof. Every 100L of compound astragalus polysaccharide injection used for the pigs contains the following raw materials, such as 0.5-5kg of astragalus polysaccharide, 1-10kg of lincomycin, 5-30kg of analginum, 1-10kg of inosine, 3-6L of 2-hydroxyl ethylamine and the like, wherein the astragalus polysaccharide can accelerate the lymphocyte to be converted and increased in value and accelerate the phagocytic function of macrophage; the lincomycin has strong antibiosis efficacy; the astragalus polysaccharide and the lincomycin are organically combined to perform an antiviral function, widen an antibacterial spectrum and enhance a targeted action on bacteria; the analginum has various functions of resisting bacterium, diminishing inflammation, carrying out antipyretic action, relieving pain and the like; and the inosine is favorable for restoring the function of a damaged hepaticcell. Above medicines have a reasonable formula, can simultaneously carry out symptomatic treatment and etiological treatment by aiming at diseases, has quick curative effect on mixed infection of pig virus and bacteria and treats both principal and secondary aspect of the disease, the medicine resistance of the pathogenic microorganism is lowered, the clinic symptom of a diseased pig is alleviated, and therefore the pig is quickly restored.
Owner:ZHENGZHOU BARY ANIMAL PHARMA

Medicine for local soaking type targeted treatment of meniscus injury through administration in knuckle articular cavity

The invention especially relates to a medicine for local soaking type targeted treatment of meniscus injury through administration in knuckle articular cavity, belonging to the field of medical technology. The medicine comprises the following components: two ampoules of high-molecular sodium hyaluronate, wherein each ampoule has a volume of 2 ml and contains 25 mg of high-molecular sodium hyaluronate; two ampoules of lincomycin, wherein each ampoule has a volume of 5 ml and contains 0.6 g of lincomycin; two ampoules of dexamethasone, wherein each ampoule has a volume of 1 ml and contains 5 mg of dexamethasone; and one ampoule of normal saline, wherein the ampoule has a volume of 10 ml. The medicine provided by the invention is mainly prepared from high-molecular sodium hyaluronate, lincomycin, dexamethasone, normal saline and other drugs according to or partially according to certain composition and dosage; cooperatively used drugs are a non-ionic iodine contrast agent solution and a lidocaine local anesthetic; and the medicine can be organically combined with a variety of meniscus diagnosis and treatment means, is simple, safe, practical and efficient, has reliable curative effect and can effectively treat meniscus injury.
Owner:袁明远
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products